News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
《大行》瑞銀降康希諾生物(06185.HK)目標價至52.4元 首季業績符預期
瑞銀發表研究報告指，康希諾生物(06185.HK)今年首季業績符合預期。期內，收入為1.9億元人民幣(下同)，按年增長38.7%，略高於該行預測2026年全年34%的增長；淨虧損為4,000萬元，對比該行預測今年全年盈利3.37億元。瑞銀調整集團2026年至2028年每股盈利預測，由原先的1.36元、2.26元及3.77元分別下調至0.77元、2.15元及3...
Reset
Send
The window will close in 5 seconds
《大行》瑞銀降康希諾生物(06185.HK)目標價至52.4元 首季業績符預期
Close
Recommend
4
Positive
2
Negative
2
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get Level 1 Real-Time Streaming!

瑞銀發表研究報告指，康希諾生物(06185.HK)  -0.460 (-1.542%)    Short selling $2.23M; Ratio 8.875%   今年首季業績符合預期。期內，收入為1.9億元人民幣(下同)，按年增長38.7%，略高於該行預測2026年全年34%的增長；淨虧損為4,000萬元，對比該行預測今年全年盈利3.37億元。

瑞銀調整集團2026年至2028年每股盈利預測，由原先的1.36元、2.26元及3.77元分別下調至0.77元、2.15元及3.58元。目標價由59.8港元下調至52.4港元；評級「買入」。(hc/da)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-30 16:25.)

AASTOCKS新聞

Switch to Auto-Translated Version
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.